Archives: Sponsors

Pfizer

|

October 21, 2016

|

« Previous 1 2 3 Next »

Or Search Our Site By Topic:

Advocacy advocacy ALK+ awareness biomarker biomarker testing chemotherapy clinical trial Clinical Trials clinical trials combination therapy Detection Diagnosis diagnosis early detection education EGFR EGFR mutation Fundraising genomic testing immunotherapy Immunotherapy KRAS latest research Living with Lung Cancer Lung Cancer Info lung cancer research non-smoker NSCLC patient support personalized medicine radiation Research ROS1 SCLC small cell lung cancer speakers bureau stage 4 Survivors Targeted therapy targeted therapy Treatment treatment Tributes Uncategorized

More

About Us
About Lung Cancer
Research
Living with Lung Cancer
Get Involved

Give with Confidence

Our Mission

LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.

Latest In Research

03/9
2023

Keytruda Meets Trial Goals for Non-Small Cell Lung Cancer Treatment

In the phase 3 KEYNOTE-671 trial evaluating Keytruda (pembrolizumab) as preoperative treatment (a regimen given before and after surgier) in patients with resectable stage 2, 3a or 3b non-small cell lung cancer has met one of its primary e…

Sign up

Get the latest news about lung cancer research.

Connect with us

Sponsors | Legal and Privacy | Media Contact | State Fundraising Notices